Stocks with Implied Volatility Movement

Go back to Stocks with Implied Volatility Movement

Gilead Sciences (GILD) PT Raised to $76 at BMO Capital Following 1Q

May 3, 2017 9:17 AM EDT

BMO Capital raised its price target on Gilead Sciences (NASDAQ: GILD) to $76.00 (from $75.00) while maintaining a Market Perform rating. GILD reported 1Q revenues of $6.5bn, below the Street's estimates of $6.62bn, as continued strength from HIV could not off-set further deterioration in HCV.

GILD... More